Editorial comment on: tumour grade, treatment, and relative survival in a population-based cohort of men with potentially curable prostate cancer.
Gallina
Andrea
A
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use*; D002454:Cell Differentiation; D006801:Humans; D008297:Male; D009367:Neoplasm Staging; D010166:Palliative Care; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D017430:Prostate-Specific Antigen / Q000097:blood; D011468:Prostatectomy / Q000401:mortality; D011471:Prostatic Neoplasms / Q000097:blood / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D011878:Radiotherapy; D018570:Risk Assessment; D012307:Risk Factors; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome; D057832:Watchful Waiting
D018931:Antineoplastic Agents, Hormonal; D017430:Prostate-Specific Antigen